Orgenesis Inc.
ORGSDelisted May 8, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001460602
Orgenesis Inc. was delisted on May 8, 2025; its insiders filed their last Form 4 on Dec 16, 2024; 1 institution reported holding it in 13F filings for Q1 2025, worth $124.0K in total; no superinvestor held it.
13F holders, Q1 2022
Institutional positions in Orgenesis Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 23
- −4 vs. Q4 2021
- Shares held
- 2.95M
- −100.1K (−3.3%) vs. Q4 2021
- Total value
- $10.2M
- +$1.45M (+16.5%) vs. Q4 2021
- New holders
- 1
- 1 more added
- Sold out
- 5
- 13 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ORGS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $20.8K |
| Q1 2026 | 1 | $30.4K |
| Q4 2025 | 1 | $7.59K |
| Q3 2025 | 1 | $50.6K |
| Q2 2025 | 1 | $74.7K |
| Q1 2025 | 1 | $124.0K |
| Q4 2024 | 1 | $95.7K |
| Q3 2024 | 12 | $958.5K |
| Q2 2024 | 20 | $1.31M |
| Q1 2024 | 18 | $1.82M |
| Q4 2023 | 21 | $1.10M |
| Q3 2023 | 22 | $1.37M |
| Q2 2023 | 23 | $3.93M |
| Q1 2023 | 21 | $3.15M |
| Q4 2022 | 21 | $4.33M |
| Q3 2022 | 23 | $4.15M |
| Q2 2022 | 22 | $7.07M |
| Q1 2022 | 23 | $10.2M |
| Q4 2021 | 27 | $8.78M |
| Q3 2021 | 28 | $15.5M |
| Q2 2021 | 34 | $17.8M |
| Q1 2021 | 40 | $30.0M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Orgenesis Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Knoll Capital Management, LLC | 1,316,364 | $4.57M | 2.87% | 00.0% | Unchanged |
| Vanguard Group Inc | 924,351 | $3.21M | 0.00% | −3,659−0.4% | Reduced |
| Geode Capital Management, LLC | 196,952 | $683.0K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 127,722 | $444.0K | 0.00% | −2,583−2.0% | Reduced |
| State Street Corp | 88,659 | $308.0K | 0.00% | +6,159+7.5% | Added |
| Renaissance Technologies LLC | 57,699 | $200.0K | 0.00% | −6,000−9.4% | Reduced |
| Ronit Capital LLP | 54,167 | $188.0K | 0.25% | 00.0% | Unchanged |
| Northern Trust Corp | 38,631 | $134.0K | 0.00% | 00.0% | Unchanged |
| Bank Hapoalim BM | 32,052 | $111.0K | 0.01% | 00.0% | Unchanged |
| D. E. Shaw & Co., Inc. | 25,053 | $87.0K | 0.00% | −100−0.4% | Reduced |
| Dimensional Fund Advisors LP | 23,768 | $82.0K | 0.00% | −200−0.8% | Reduced |
| Kennedy Capital Management, Inc. | 19,514 | $68.0K | 0.00% | +19,514 | New |
| Virtu Financial LLC | 13,090 | $45.0K | 0.00% | −19,758−60.1% | Reduced |
| Millennium Management LLC | 10,003 | $35.0K | 0.00% | −11,835−54.2% | Reduced |
| Morgan Stanley | 7,438 | $26.0K | 0.00% | −22−0.3% | Reduced |
| Barclays PLC | 7,279 | $25.0K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 3,718 | $13.0K | 0.00% | −434−10.5% | Reduced |
| Simplex Trading, LLC | 1,966 | $6.00K | 0.00% | −2,507−56.0% | Reduced |
| TSFG, LLC | 1,000 | $3.00K | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 89 | $309 | 0.00% | −281−75.9% | Reduced |
| Tower Research Capital LLC (TRC) | 68 | $0 | 0.00% | −1,597−95.9% | Reduced |
| Wells Fargo & Company | 133 | $0 | 0.00% | −450−77.2% | Reduced |
| JPMorgan Chase & Co | 95 | $0 | 0.00% | 00.0% | Unchanged |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −21,762−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −18,270−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −14,692−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −12,400−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −9,210−100.0% | Sold out |